Search Results
Search for other papers by Ran Rostoker in
Google Scholar
PubMed
Search for other papers by Sagi Abelson in
Google Scholar
PubMed
Search for other papers by Keren Bitton-Worms in
Google Scholar
PubMed
Search for other papers by Inna Genkin in
Google Scholar
PubMed
Search for other papers by Sarit Ben-Shmuel in
Google Scholar
PubMed
Search for other papers by Maria Dakwar in
Google Scholar
PubMed
Search for other papers by Zila Shen Orr in
Google Scholar
PubMed
Search for other papers by Avishay Caspi in
Google Scholar
PubMed
Search for other papers by Maty Tzukerman in
Google Scholar
PubMed
Clinical Research Institute at Rambam (CRIR) and the Faculty of Medicine, The Laboratory of Molecular Medicine, Division of Endocrinology, Technion, Diabetes and Metabolism Clinical Research Center of Excellence, Haifa, Israel
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
277 – 289 . ( doi:10.1007/s10911-013-9303-7 ). Belfiore A Frittitta L Costantino A Frasca F Pandini G Sciacca L Goldfine I Vigneri R 1996 Insulin receptors in breast cancer . Annals of the New York Academy of Sciences 784 173
Search for other papers by Carolin Maria Frisch in
Google Scholar
PubMed
Search for other papers by Katrin Zimmermann in
Google Scholar
PubMed
Search for other papers by Pia Zilleßen in
Google Scholar
PubMed
Search for other papers by Alexander Pfeifer in
Google Scholar
PubMed
Search for other papers by Kurt Racké in
Google Scholar
PubMed
Search for other papers by Peter Mayer in
Google Scholar
PubMed
. 2009 ). However, recent studies give evidence that the insulin receptor (IR) itself plays a crucial role in malignancies ( Frasca et al . 2008 ). Importantly, Kim et al . (2012) further revealed for the first time the impact of IR in survival of non
Search for other papers by Antonino Belfiore in
Google Scholar
PubMed
Search for other papers by Roberta Malaguarnera in
Google Scholar
PubMed
Introduction The insulin receptor (IR) and the IGF1 receptor (IGF1R), both evolved from a common ancestor gene, represent fundamental regulators of glucose metabolism and growth, respectively, in response to nutrient availability. It is now well
Search for other papers by Zara Zelenko in
Google Scholar
PubMed
Search for other papers by Emily Jane Gallagher in
Google Scholar
PubMed
Search for other papers by Irini Markella Antoniou in
Google Scholar
PubMed
Search for other papers by Deepali Sachdev in
Google Scholar
PubMed
Search for other papers by Anupma Nayak in
Google Scholar
PubMed
Search for other papers by Douglas Yee in
Google Scholar
PubMed
Search for other papers by Derek LeRoith in
Google Scholar
PubMed
endogenous hyperinsulinemia profoundly increased the growth of human LCC6 cancers and that insulin receptor knockdown led to significantly decreased tumor growth in control and hyperinsulinemic mice. Furthermore, the knockdown of the insulin receptor led to
Search for other papers by Dawei Wu in
Google Scholar
PubMed
Search for other papers by Dongwei Lv in
Google Scholar
PubMed
Search for other papers by Ting Zhang in
Google Scholar
PubMed
Search for other papers by Lianying Guo in
Google Scholar
PubMed
Search for other papers by Fangli Ma in
Google Scholar
PubMed
Search for other papers by Caihua Zhang in
Google Scholar
PubMed
Search for other papers by Guofeng Lv in
Google Scholar
PubMed
Search for other papers by Lin Huang in
Google Scholar
PubMed
patients is associated with hyperinsulinemia which stimulates the proliferation of epithelial cells ( Gualberto & Pollak 2009 , Pollak 2012 ). The holo-insulin receptor (IR) formation and the signaling of IR pathway is activated by IGF1R depletion ( Zhang
Search for other papers by Gail E de Blaquière in
Google Scholar
PubMed
Search for other papers by Felicity E B May in
Google Scholar
PubMed
Search for other papers by Bruce R Westley in
Google Scholar
PubMed
Introduction The insulin-like growth factor (IGF) system comprises two ligands (IGF-1 and IGF-2) as well as the closely related hormone insulin, six binding proteins (IGFBP1-6), three receptors (type I and type II IGF and the insulin receptors) and
Search for other papers by V Costa in
Google Scholar
PubMed
Search for other papers by D Foti in
Google Scholar
PubMed
Search for other papers by F Paonessa in
Google Scholar
PubMed
Search for other papers by E Chiefari in
Google Scholar
PubMed
Search for other papers by L Palaia in
Google Scholar
PubMed
Search for other papers by G Brunetti in
Google Scholar
PubMed
Search for other papers by E Gulletta in
Google Scholar
PubMed
Search for other papers by A Fusco in
Google Scholar
PubMed
Search for other papers by A Brunetti in
Google Scholar
PubMed
peptide hormone insulin is a major regulator of glucose homeostasis and cell growth. The first step in insulin action is the binding of the hormone to the insulin receptor (IR), a phylogenetically ancient receptor protein embedded in the plasma membrane of
Search for other papers by Carly Jade Dool in
Google Scholar
PubMed
Search for other papers by Haider Mashhedi in
Google Scholar
PubMed
Search for other papers by Mahvash Zakikhani in
Google Scholar
PubMed
Search for other papers by Stéphanie David in
Google Scholar
PubMed
Search for other papers by Yunhua Zhao in
Google Scholar
PubMed
Search for other papers by Elena Birman in
Google Scholar
PubMed
Search for other papers by Joan M Carboni in
Google Scholar
PubMed
Search for other papers by Marco Gottardis in
Google Scholar
PubMed
Search for other papers by Marie-José Blouin in
Google Scholar
PubMed
Search for other papers by Michael Pollak in
Google Scholar
PubMed
Introduction Experimental evidence that certain cancers are mitogenically responsive to insulin has been available for decades ( Heuson et al . 1967 ) and is consistent with recent work demonstrating growth inhibitory effects of insulin receptor
Laboratory of Molecular Oncology, School of Molecular Medicine, Institut Gustave Roussy, Emory University School of Medicine, Department of Oncology, Military Institute of Medicine, Szaserow 128, 04‐141 Warsaw, Poland
Search for other papers by W Solarek in
Google Scholar
PubMed
Search for other papers by A M Czarnecka in
Google Scholar
PubMed
Search for other papers by B Escudier in
Google Scholar
PubMed
Laboratory of Molecular Oncology, School of Molecular Medicine, Institut Gustave Roussy, Emory University School of Medicine, Department of Oncology, Military Institute of Medicine, Szaserow 128, 04‐141 Warsaw, Poland
Search for other papers by Z F Bielecka in
Google Scholar
PubMed
Search for other papers by F Lian in
Google Scholar
PubMed
Search for other papers by C Szczylik in
Google Scholar
PubMed
tetrameric complex, characterized by two halves, which consist of an extracellular α-chain that is involved in ligand binding and an intracellular β-chain with functional tyrosine kinase (TK) domain. In adult tissues, insulin receptor (IR) is mainly expressed
Search for other papers by J Riedemann in
Google Scholar
PubMed
Search for other papers by V M Macaulay in
Google Scholar
PubMed
tyrosine kinase (RTK) that is responsible for mediating IGF bioactivity. The IGF1R gene is located on chromosome 15q26 and encodes a single polypeptide of 1367 amino acids that is constitutively expressed in most cells. The IGF1R and insulin receptor (IR